Home
About RISK-HUNT3R
Partners & Collaborations
Publications
Resource centre
News and updates
ASPA
Contact
EU-ToxRisk Legacy

Home
About RISK-HUNT3R
Partners & Collaborations
Publications
Resource centre
News and updates
ASPA
Contact
EU-ToxRisk Legacy

An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition

Mar 24, 2022 | 2018, Archives of Toxicology, Publication - legacy work

Search for:

Recent Posts

Assessment of pulmonary fibrosis using weighted gene co-expression network analysis
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study
MolCompass: multi-tool for the navigation in chemical space and visual validation of QSAR/QSPR models
PathwayNexus: a tool for interactive metabolic data analysis
Knowledge infrastructure for integrated data management and analysis supporting new approach methods in predictive toxicology and risk assessment

Terms of Service

Legal Notice & Disclaimer
Privacy Policy
Copyright

Contact

mt|brightness_low|

riskhunt3r_contact
@eurtd.com

mt|brightness_low|

riskhunt3r_contact@eurtd.com

Search

Search for:

Follow us

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964537.

Copyright © RISK-HUNT3R 2025

EU Disclaimer: The content of this website reflects only the author’s view; the Commission is not responsible for any use that may be made of the information it contains.